Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease

European Journal of Human Genetics

Volumn 14, Issue 3, 2006, Pages 322-331

  Di Fonzo, Alessio ^a,x   Tassorelli, C ^b   De Mari, Michele ^c   Chien, Hsin F ^d   Ferreira, Joaquim ^e   Rohé, Christan F ^a   Riboldazzi, Giulio ^f   Antonini, Angelo ^g   Albani, Gianni ^h   Mauro, Alessandro ^h,i   Marconi, Roberto ^j   Abbruzzese, Giovanni ^k   Lopiano, Leonardo ⁱ   Fincati, Emiliana ^l   Guidi, Marco ^m   Marini, Paolo ⁿ   Stocchi, Fabrizio ^o   Onofrj, Marco ^p   Toni, Vincenzo ^q   Tinazzi, Michele ^r   Fabbrini, Giovanni ^s   Lamberti, Paolo ^c   Vanacore, Nicola ^t   Meco, Giuseppe ^s   Leitner, Petra ^u   Uitti, Ryan J ^v   Wszolek, Zbigniew K ^v   Gasser, Thomas ^u   Simons, Erik J ^a   Breedveld, Guido J ^a   Goldwurm, Stefano ^g   Pezzoli, Gianni ^g   Sampaio, Cristina ^e   Barbosa, Egberto ^d   Martignoni, Emilia ^w,y   Oostra, Ben A ^a   Bonifati, Vincenzo ^a,s   Vancore, N ^z   Fabrizio, E ^z   Locuratolo, N ^z   Martini, L ^z   Scoppetta, C ^z   Colosimo, C ^z   Manfredi, Ma ^z   Lopiano, L ⁱ   Tavella, A ⁱ   Bergamasco, B ⁱ   Pacchetti, C ^b   Nappi, G ^b   Canesi, M ^g   Calandrella, D ^f   Brono, G ^f   Manfredi, Mi ^aa   Raudino, F ^ab   Corengia, E ^ab   Bonizzato, A ^l   Ferracci, C ^r   Dalla Libera, A ^ac   Marchese, R ^ad   Montagna, P ^k   Ramat, S ^ae   Massaro, F ^ae   Minardi, C ⁿ   Rasi, F ⁿ   Thomas, A ^af   Vacca, L ^o   De Pandis, F ^ag   Diroma, C ^c   Iliceto, G ^c   Lamberti, P ^c   Toni, V ^q   Trianni, G ^q   Mauro, A ^ah   De Gaetano, A ^ai   Rizzo, M ^aj   Cossu, G ^ak   more..

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^c UNIVERSITY OF BARI   (Italy)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e INSTITUTO DE MEDICINA MOLECULAR JOÃO LOBO ANTUNES   (Portugal)

^f UNIVERSITY OF INSUBRIA   (Italy)

^g PARKINSON INSTITUTE   (Italy)

^h ISTITUTO AUXOLOGICO ITALIANO   (Italy)

ⁱ UNIVERSITY OF TURIN   (Italy)

^j MISERICORDIA HOSPITAL   (Italy)

^k UNIVERSITY OF GENOA   (Italy)

^l UNIVERSITY OF VERONA   (Italy)

^m INRCA   (Italy)

ⁿ UNIVERSITY OF FLORENCE   (Italy)

^o IRCCS NEUROMED   (Italy)

^p UNIVERSITY OF CHIETI   (Italy)

^q Hospital Casarano   (Italy)

^r BORGO TRENTO HOSPITAL   (Italy)

^s SAPIENZA UNIVERSITY OF ROME   (Italy)

^t ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^u UNIVERSITY OF TÜBINGEN   (Germany)

^v MAYO CLINIC   (United States)

^w IRCCS   (Italy)

^x UNIVERSITY OF MILAN   (Italy)

^y UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^z SAPIENZA UNIVERSITY OF ROME   (Italy)

^aa 'Poliambulanza' Hospital   (Italy)

^ab Sant'Anna Como Hospital   (Italy)

^ac Belluno Hospital   (Italy)

^ad 'Boldrini' Hospital   (Italy)

^ae UNIVERSITY OF BOLOGNA   (Italy)

^af 'Bufanili' Hospital   (Italy)

^ag 'Villa Margherita' Hospital   (Italy)

^ah Hospital of Salerno   (Italy)

^ai Hospital of Castrovillari   (Italy)

^aj University Hospital of Palermo   (Italy)

^ak San Michele Hospital   (Italy)

more..

Author keywords

Autosomal dominant; Familial; LRRK2; Mutation; PARK8; Parkinson

Indexed keywords

LEUCINE RICH REPEAT KINASE 2; LEVODOPA; PHOSPHOTRANSFERASE; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DISEASE COURSE; EXON; FAMILY ASSESSMENT; GENE CLUSTER; GENE MUTATION; GENE SEGREGATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HETEROZYGOSITY; HUMAN; HUMAN GENOME; INTRON; ITALY; MAJOR CLINICAL STUDY; MOLECULAR DYNAMICS; MUTATION RATE; NUCLEOTIDE SEQUENCE; ONSET AGE; OPEN READING FRAME; PARKINSON DISEASE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; RNA SPLICING;

EID: 33645139675     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201539     Document Type: Article

References (32)

1. Bonifati V, Oostra BA, Heutink P: Unraveling the pathogenesis of Parkinson's disease - the contribution of monogenic forms. Cell Mol Life Sci 2004; 61: 1729-1750.
2. Dawson TM, Dawson VL: Molecular pathways of neurodegeneration in Parkinson's disease. Science 2003; 302: 819-822.
3. Polymeropoulos MH, Lavedan C, Leroy E et al: Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997; 276: 2045-2047.
4. Singleton AB, Farrer M, Johnson J et al: Alpha-Synuclein locus triplication causes Parkinson's disease. Science 2003; 302: 841.
5. Kitada T, Asakawa S, Hattori N et al: Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998; 392: 605-608.
6. Bonifati V, Rizzu P, van Baren MJ et al: Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 2003; 299: 256-259.
7. Valente EM, Abou-Sleiman PM, Caputo V et al: Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 2004; 304: 1158-1160.
8. Funayama M, Hasegawa K, Kowa H, Saito M, Tsuji S, Obata F: A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1. Ann Neurol 2002; 51: 296-301.
9. Zimprich A, Biskup S, Leitner P et al: Mutations in LRRK2 Cause autosomal-dominant Parkinsonism with pleomorphic pathology. Neuron 2004; 44: 601-607.
10. Paisan-Ruiz C, Jain S, Evans EW et al: Cloning of the gene containing mutations that cause PARK8-Linked Parkinson's disease. Neuron 2004; 44: 595-600.
11. Bosgraaf L, Van Haastert PJ: Roc, a Ras/GTPase domain in complex proteins. Biochim Biophys Acta 2003; 1643: 5-10.
12. Di Fonzo A, Rohe CF, Ferreira J et al: A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease. Lancet 2005; 365: 412-415.
13. Hernandez DG, Paisan-Ruiz C, McInerney-Leo A et al: Clinical and positron emission tomography of Parkinson's disease caused by LRRK2. Ann Neurol 2005; 57: 453-456.
14. Kachergus J, Mata IF, Hulihan M et al: Identification of a novel LRRK2 mutation Linked to autosomal dominant parkinsonism: Evidence of a common founder across european populations. Am J Hum Genet 2005; 76: 672-680.
15. Funayama M, Hasegawa K, Ohta E et al: An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family. Ann Neurol 2005; 57: 918-921.
16. Farrer M, Stone J, Mata IF et al: LRRK2 mutations in Parkinson disease. Neurology 2005; 65: 738-740.
17. Zabetian CP, Samii A, Mosley AD et al: A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations. Neurology 2005; 65: 741-744.
18. Paisan-Ruiz C, Lang AE, Kawarai T et al: LRRK2 gene in Parkinson disease: Mutation analysis and case control association study. Neurology 2005; 65: 696-700.
19. Gilks WP, Abou-Sleiman PM, Gandhi S et al: A common LRRK2 mutation in idiopathic Parkinson's disease. Lancet 2005; 365: 415-416.
20. Nichols WC, Pankratz N, Hernandez D et al: Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease. Lancet 2005; 365: 410-412.
21. Mata IF, Taylor JP, Kachergus J et al: LRRK2 R1441G in Spanish patients with Parkinson's disease. Neurosci Lett 2005; 382: 309-311.
22. Tan EK, Shen H, Tan LC et al: The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients. Neurosci Lett 2005; 384: 327-329.
23. Aasly JO, Toft M, Fernandez-Mata I et al: Clinical features of LRRK2-associated Parkinson's disease in central Norway. Ann Neurol 2005; 57: 762-765.
24. Deng H, Le W, Guo Y, Hunter CB, Xie W, Jankovic J: Genetic and clinical identification of Parkinson's disease patients with LRRK2 G2019S mutation. Ann Neurol 2005; 57: 933-934.
25. Hughes AJ, Daniel SE, Kilford L, Lees AJ: Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-184.
26. Fahn S, Elton RL: Unified Parkinson's disease rating scale. Recent Developments in Parkinson's Disease. New York: Macmillan 1987; 153-163.
27. Goldwurm S, Di Fonzo A, Simons EJ et al: The G6055A (G2019S) mutation in LRRK2 is frequent in both early - and late-onset Parkinson's disease and originates from a common ancestor. J Med Genet 2005; 42: E65.
28. Lesage S, Leutenegger A-L, Ibanez P et al: LRRK2 Haplotype analyses in European and North African families with Parkinson's disease: A common founder for the G2019S mutation dating from the 13th century. Am J Hum Genet 2005; 77: 330-332.
29. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S: The protein kinase complement of the human genome. Science 2002; 298: 1912-1934.
30. Nolen B, Taylor S, Ghosh G: Regulation of protein kinases; controlling activity through activation segment conformation. Mol Cell 2004; 15: 661-675.
31. Davies H, Bignell GR, Cox C et al: Mutations of the BRAF gene in human cancer. Nature 2002; 417: 949-954.
32. Wszolek ZK, Pfeiffer RF, Tsuboi Y et al: Autosomal dominant parkinsonism associated with variable synuclein and tau pathology. Neurology 2004; 62: 1619-1622.